Table of Content

1 Dermatological Medicine Market Overview
1.1 Product Overview and Scope of Dermatological Medicine
1.2 Dermatological Medicine Segment by Type
1.2.1 Global Dermatological Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti-acne
1.2.5 Calcineurin Inhibitors
1.2.6 Retinoids
1.2.7 Others
1.3 Dermatological Medicine Segment by Application
1.3.1 Global Dermatological Medicine Market Value by Application: (2024-2034)
1.3.2 Alopecia
1.3.3 Herpes
1.3.4 Psoriasis
1.3.5 Rosacea
1.3.6 Atopic Dermatitis
1.3.7 Others
1.4 Global Dermatological Medicine Market Size Estimates and Forecasts
1.4.1 Global Dermatological Medicine Revenue 2018-2034
1.4.2 Global Dermatological Medicine Sales 2018-2034
1.4.3 Global Dermatological Medicine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Dermatological Medicine Market Competition by Manufacturers
2.1 Global Dermatological Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dermatological Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dermatological Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Dermatological Medicine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatological Medicine, Product Type & Application
2.7 Dermatological Medicine Market Competitive Situation and Trends
2.7.1 Dermatological Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dermatological Medicine Players Market Share by Revenue
2.7.3 Global Dermatological Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dermatological Medicine Retrospective Market Scenario by Region
3.1 Global Dermatological Medicine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Dermatological Medicine Global Dermatological Medicine Sales by Region: 2018-2034
3.2.1 Global Dermatological Medicine Sales by Region: 2018-2023
3.2.2 Global Dermatological Medicine Sales by Region: 2024-2034
3.3 Global Dermatological Medicine Global Dermatological Medicine Revenue by Region: 2018-2034
3.3.1 Global Dermatological Medicine Revenue by Region: 2018-2023
3.3.2 Global Dermatological Medicine Revenue by Region: 2024-2034
3.4 North America Dermatological Medicine Market Facts & Figures by Country
3.4.1 North America Dermatological Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Dermatological Medicine Sales by Country (2018-2034)
3.4.3 North America Dermatological Medicine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dermatological Medicine Market Facts & Figures by Country
3.5.1 Europe Dermatological Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Dermatological Medicine Sales by Country (2018-2034)
3.5.3 Europe Dermatological Medicine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatological Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Dermatological Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Dermatological Medicine Sales by Country (2018-2034)
3.6.3 Asia Pacific Dermatological Medicine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dermatological Medicine Market Facts & Figures by Country
3.7.1 Latin America Dermatological Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Dermatological Medicine Sales by Country (2018-2034)
3.7.3 Latin America Dermatological Medicine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermatological Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatological Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Dermatological Medicine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Dermatological Medicine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermatological Medicine Sales by Type (2018-2034)
4.1.1 Global Dermatological Medicine Sales by Type (2018-2023)
4.1.2 Global Dermatological Medicine Sales by Type (2024-2034)
4.1.3 Global Dermatological Medicine Sales Market Share by Type (2018-2034)
4.2 Global Dermatological Medicine Revenue by Type (2018-2034)
4.2.1 Global Dermatological Medicine Revenue by Type (2018-2023)
4.2.2 Global Dermatological Medicine Revenue by Type (2024-2034)
4.2.3 Global Dermatological Medicine Revenue Market Share by Type (2018-2034)
4.3 Global Dermatological Medicine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Dermatological Medicine Sales by Application (2018-2034)
5.1.1 Global Dermatological Medicine Sales by Application (2018-2023)
5.1.2 Global Dermatological Medicine Sales by Application (2024-2034)
5.1.3 Global Dermatological Medicine Sales Market Share by Application (2018-2034)
5.2 Global Dermatological Medicine Revenue by Application (2018-2034)
5.2.1 Global Dermatological Medicine Revenue by Application (2018-2023)
5.2.2 Global Dermatological Medicine Revenue by Application (2024-2034)
5.2.3 Global Dermatological Medicine Revenue Market Share by Application (2018-2034)
5.3 Global Dermatological Medicine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson and Johnson Dermatological Medicine Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Dermatological Medicine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Dermatological Medicine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AbbVie Dermatological Medicine Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bayer Dermatological Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck Dermatological Medicine Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Reckitt Benckiser
6.6.1 Reckitt Benckiser Corporation Information
6.6.2 Reckitt Benckiser Description and Business Overview
6.6.3 Reckitt Benckiser Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Reckitt Benckiser Dermatological Medicine Product Portfolio
6.7.5 Reckitt Benckiser Recent Developments/Updates
6.8 Taisho Pharmaceutical
6.8.1 Taisho Pharmaceutical Corporation Information
6.8.2 Taisho Pharmaceutical Description and Business Overview
6.8.3 Taisho Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Taisho Pharmaceutical Dermatological Medicine Product Portfolio
6.8.5 Taisho Pharmaceutical Recent Developments/Updates
6.9 Perrigo
6.9.1 Perrigo Corporation Information
6.9.2 Perrigo Description and Business Overview
6.9.3 Perrigo Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Perrigo Dermatological Medicine Product Portfolio
6.9.5 Perrigo Recent Developments/Updates
6.10 Ikeda Mohando
6.10.1 Ikeda Mohando Corporation Information
6.10.2 Ikeda Mohando Description and Business Overview
6.10.3 Ikeda Mohando Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ikeda Mohando Dermatological Medicine Product Portfolio
6.10.5 Ikeda Mohando Recent Developments/Updates
6.11 DermaPharm A/S
6.11.1 DermaPharm A/S Corporation Information
6.11.2 DermaPharm A/S Dermatological Medicine Description and Business Overview
6.11.3 DermaPharm A/S Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 DermaPharm A/S Dermatological Medicine Product Portfolio
6.11.5 DermaPharm A/S Recent Developments/Updates
6.12 LEO Pharma
6.12.1 LEO Pharma Corporation Information
6.12.2 LEO Pharma Dermatological Medicine Description and Business Overview
6.12.3 LEO Pharma Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 LEO Pharma Dermatological Medicine Product Portfolio
6.12.5 LEO Pharma Recent Developments/Updates
6.13 China Resources Pharmaceutical Group
6.13.1 China Resources Pharmaceutical Group Corporation Information
6.13.2 China Resources Pharmaceutical Group Dermatological Medicine Description and Business Overview
6.13.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio
6.13.5 China Resources Pharmaceutical Group Recent Developments/Updates
6.14 Chongqing Huapont Pharm Co.
6.14.1 Chongqing Huapont Pharm Co. Corporation Information
6.14.2 Chongqing Huapont Pharm Co. Dermatological Medicine Description and Business Overview
6.14.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio
6.14.5 Chongqing Huapont Pharm Co. Recent Developments/Updates
6.15 Bright Future Pharmaceutical
6.15.1 Bright Future Pharmaceutical Corporation Information
6.15.2 Bright Future Pharmaceutical Dermatological Medicine Description and Business Overview
6.15.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Bright Future Pharmaceutical Dermatological Medicine Product Portfolio
6.15.5 Bright Future Pharmaceutical Recent Developments/Updates
6.16 Xiuzheng Pharmaceutical Group
6.16.1 Xiuzheng Pharmaceutical Group Corporation Information
6.16.2 Xiuzheng Pharmaceutical Group Dermatological Medicine Description and Business Overview
6.16.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio
6.16.5 Xiuzheng Pharmaceutical Group Recent Developments/Updates
6.17 China National Pharmaceutical Group
6.17.1 China National Pharmaceutical Group Corporation Information
6.17.2 China National Pharmaceutical Group Dermatological Medicine Description and Business Overview
6.17.3 China National Pharmaceutical Group Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 China National Pharmaceutical Group Dermatological Medicine Product Portfolio
6.17.5 China National Pharmaceutical Group Recent Developments/Updates
6.18 Harbin Letai
6.18.1 Harbin Letai Corporation Information
6.18.2 Harbin Letai Dermatological Medicine Description and Business Overview
6.18.3 Harbin Letai Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Harbin Letai Dermatological Medicine Product Portfolio
6.18.5 Harbin Letai Recent Developments/Updates
6.19 Hebei Xinglong Xili Pharmaceutical
6.19.1 Hebei Xinglong Xili Pharmaceutical Corporation Information
6.19.2 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Description and Business Overview
6.19.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio
6.19.5 Hebei Xinglong Xili Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatological Medicine Industry Chain Analysis
7.2 Dermatological Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatological Medicine Production Mode & Process
7.4 Dermatological Medicine Sales and Marketing
7.4.1 Dermatological Medicine Sales Channels
7.4.2 Dermatological Medicine Distributors
7.5 Dermatological Medicine Customers
8 Dermatological Medicine Market Dynamics
8.1 Dermatological Medicine Industry Trends
8.2 Dermatological Medicine Market Drivers
8.3 Dermatological Medicine Market Challenges
8.4 Dermatological Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dermatological Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dermatological Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dermatological Medicine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dermatological Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Dermatological Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Dermatological Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Dermatological Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Dermatological Medicine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Dermatological Medicine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Dermatological Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dermatological Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Dermatological Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dermatological Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Medicine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dermatological Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Dermatological Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Dermatological Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Dermatological Medicine Sales by Region (2024-2034) & (K Units)
Table 20. Global Dermatological Medicine Sales Market Share by Region (2024-2034)
Table 21. Global Dermatological Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Dermatological Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Dermatological Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dermatological Medicine Revenue Market Share by Region (2024-2034)
Table 25. North America Dermatological Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Dermatological Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Dermatological Medicine Sales by Country (2024-2034) & (K Units)
Table 28. North America Dermatological Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Dermatological Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dermatological Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Dermatological Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Dermatological Medicine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Dermatological Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Dermatological Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dermatological Medicine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Dermatological Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Dermatological Medicine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Dermatological Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Dermatological Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dermatological Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Dermatological Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Dermatological Medicine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Dermatological Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dermatological Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dermatological Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dermatological Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Dermatological Medicine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Dermatological Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dermatological Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dermatological Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Dermatological Medicine Sales (K Units) by Type (2024-2034)
Table 52. Global Dermatological Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Dermatological Medicine Sales Market Share by Type (2024-2034)
Table 54. Global Dermatological Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Dermatological Medicine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dermatological Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Dermatological Medicine Revenue Market Share by Type (2024-2034)
Table 58. Global Dermatological Medicine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Dermatological Medicine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Dermatological Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Dermatological Medicine Sales (K Units) by Application (2024-2034)
Table 62. Global Dermatological Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Dermatological Medicine Sales Market Share by Application (2024-2034)
Table 64. Global Dermatological Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Dermatological Medicine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dermatological Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Dermatological Medicine Revenue Market Share by Application (2024-2034)
Table 68. Global Dermatological Medicine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Dermatological Medicine Price (US$/Unit) by Application (2024-2034)
Table 70. Johnson and Johnson Corporation Information
Table 71. Johnson and Johnson Description and Business Overview
Table 72. Johnson and Johnson Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Johnson and Johnson Dermatological Medicine Product
Table 74. Johnson and Johnson Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. GSK Dermatological Medicine Product
Table 79. GSK Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Dermatological Medicine Product
Table 84. Pfizer Recent Developments/Updates
Table 85. AbbVie Corporation Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AbbVie Dermatological Medicine Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Bayer Dermatological Medicine Product
Table 94. Bayer Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merck Dermatological Medicine Product
Table 99. Merck Recent Developments/Updates
Table 100. Reckitt Benckiser Corporation Information
Table 101. Reckitt Benckiser Description and Business Overview
Table 102. Reckitt Benckiser Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Reckitt Benckiser Dermatological Medicine Product
Table 104. Reckitt Benckiser Recent Developments/Updates
Table 105. Taisho Pharmaceutical Corporation Information
Table 106. Taisho Pharmaceutical Description and Business Overview
Table 107. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Taisho Pharmaceutical Dermatological Medicine Product
Table 109. Taisho Pharmaceutical Recent Developments/Updates
Table 110. Perrigo Corporation Information
Table 111. Perrigo Description and Business Overview
Table 112. Perrigo Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Perrigo Dermatological Medicine Product
Table 114. Perrigo Recent Developments/Updates
Table 115. Ikeda Mohando Corporation Information
Table 116. Ikeda Mohando Description and Business Overview
Table 117. Ikeda Mohando Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Ikeda Mohando Dermatological Medicine Product
Table 119. Ikeda Mohando Recent Developments/Updates
Table 120. DermaPharm A/S Corporation Information
Table 121. DermaPharm A/S Description and Business Overview
Table 122. DermaPharm A/S Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. DermaPharm A/S Dermatological Medicine Product
Table 124. DermaPharm A/S Recent Developments/Updates
Table 125. LEO Pharma Corporation Information
Table 126. LEO Pharma Description and Business Overview
Table 127. LEO Pharma Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. LEO Pharma Dermatological Medicine Product
Table 129. LEO Pharma Recent Developments/Updates
Table 130. China Resources Pharmaceutical Group Corporation Information
Table 131. China Resources Pharmaceutical Group Description and Business Overview
Table 132. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. China Resources Pharmaceutical Group Dermatological Medicine Product
Table 134. China Resources Pharmaceutical Group Recent Developments/Updates
Table 135. Chongqing Huapont Pharm Co. Corporation Information
Table 136. Chongqing Huapont Pharm Co. Description and Business Overview
Table 137. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Chongqing Huapont Pharm Co. Dermatological Medicine Product
Table 139. Chongqing Huapont Pharm Co. Recent Developments/Updates
Table 140. Bright Future Pharmaceutical Corporation Information
Table 141. Bright Future Pharmaceutical Description and Business Overview
Table 142. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Bright Future Pharmaceutical Dermatological Medicine Product
Table 144. Bright Future Pharmaceutical Recent Developments/Updates
Table 145. Xiuzheng Pharmaceutical Group Corporation Information
Table 146. Xiuzheng Pharmaceutical Group Description and Business Overview
Table 147. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Xiuzheng Pharmaceutical Group Dermatological Medicine Product
Table 149. Xiuzheng Pharmaceutical Group Recent Developments/Updates
Table 150. China National Pharmaceutical Group Corporation Information
Table 151. China National Pharmaceutical Group Description and Business Overview
Table 152. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. China National Pharmaceutical Group Dermatological Medicine Product
Table 154. China National Pharmaceutical Group Recent Developments/Updates
Table 155. Harbin Letai Corporation Information
Table 156. Harbin Letai Description and Business Overview
Table 157. Harbin Letai Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Harbin Letai Dermatological Medicine Product
Table 159. Harbin Letai Recent Developments/Updates
Table 160. Hebei Xinglong Xili Pharmaceutical Corporation Information
Table 161. Hebei Xinglong Xili Pharmaceutical Description and Business Overview
Table 162. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product
Table 164. Hebei Xinglong Xili Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Dermatological Medicine Distributors List
Table 168. Dermatological Medicine Customers List
Table 169. Dermatological Medicine Market Trends
Table 170. Dermatological Medicine Market Drivers
Table 171. Dermatological Medicine Market Challenges
Table 172. Dermatological Medicine Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dermatological Medicine
Figure 2. Global Dermatological Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dermatological Medicine Market Share by Type in 2024 & 2034
Figure 4. Anti-infectives Product Picture
Figure 5. Corticosteroids Product Picture
Figure 6. Anti-acne Product Picture
Figure 7. Calcineurin Inhibitors Product Picture
Figure 8. Retinoids Product Picture
Figure 9. Others Product Picture
Figure 10. Global Dermatological Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Dermatological Medicine Market Share by Application in 2024 & 2034
Figure 12. Alopecia
Figure 13. Herpes
Figure 14. Psoriasis
Figure 15. Rosacea
Figure 16. Atopic Dermatitis
Figure 17. Others
Figure 18. Global Dermatological Medicine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Dermatological Medicine Market Size (2018-2034) & (US$ Million)
Figure 20. Global Dermatological Medicine Sales (2018-2034) & (K Units)
Figure 21. Global Dermatological Medicine Average Price (US$/Unit) & (2018-2034)
Figure 22. Dermatological Medicine Report Years Considered
Figure 23. Dermatological Medicine Sales Share by Manufacturers in 2024
Figure 24. Global Dermatological Medicine Revenue Share by Manufacturers in 2024
Figure 25. The Global 5 and 10 Largest Dermatological Medicine Players: Market Share by Revenue in 2024
Figure 26. Dermatological Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 27. Global Dermatological Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 28. North America Dermatological Medicine Sales Market Share by Country (2018-2034)
Figure 29. North America Dermatological Medicine Revenue Market Share by Country (2018-2034)
Figure 30. United States Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Europe Dermatological Medicine Sales Market Share by Country (2018-2034)
Figure 33. Europe Dermatological Medicine Revenue Market Share by Country (2018-2034)
Figure 34. Germany Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. France Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. U.K. Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Italy Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Russia Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Asia Pacific Dermatological Medicine Sales Market Share by Region (2018-2034)
Figure 40. Asia Pacific Dermatological Medicine Revenue Market Share by Region (2018-2034)
Figure 41. China Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Japan Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. South Korea Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. India Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Australia Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. China Taiwan Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Indonesia Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Thailand Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Malaysia Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Dermatological Medicine Sales Market Share by Country (2018-2034)
Figure 51. Latin America Dermatological Medicine Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Dermatological Medicine Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Dermatological Medicine Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. UAE Dermatological Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Dermatological Medicine by Type (2018-2034)
Figure 61. Global Revenue Market Share of Dermatological Medicine by Type (2018-2034)
Figure 62. Global Dermatological Medicine Price (US$/Unit) by Type (2018-2034)
Figure 63. Global Sales Market Share of Dermatological Medicine by Application (2018-2034)
Figure 64. Global Revenue Market Share of Dermatological Medicine by Application (2018-2034)
Figure 65. Global Dermatological Medicine Price (US$/Unit) by Application (2018-2034)
Figure 66. Dermatological Medicine Value Chain
Figure 67. Dermatological Medicine Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed